AT
Axiom Therapeutics Inc.
SEC filingOther Technology · Claymont, DE
Amount raised$12.3Msold at filing
Total offering$12.3M
Investors in the raise31count reported to the SEC
FiledAug 25, 2026first sale Aug 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sofia Patrick Hamilton DahouneDirector
Ryan John GeiserExecutive Officer, Director, Promoter
Christopher Patrick Hamilton HaggardExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.